Ophthalmology, Retina Specialist · East Setauket, NY
NPI
1306088521
Since 2009
Specialty
Ophthalmology, Retina Specialist
Code 207WX0107X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
33 Research Way
East Setauket, NY, 11733
Phone (631) 444-4090
Groups this clinician bills Medicare through
Medicare paid, 2024
$982K
12,594 services
Medicare patients, 2024
1,326
Average age 75
Drug cost, 2024
$1.6M
1,021 prescriptions
Company payments, 2025
$1,526
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Khurram M Chaudhary was code 92014 (ophthalmological e&m), 3,089 times for 1,186 patients. In total Khurram M Chaudhary billed 12,594 services in 34 codes, and Medicare paid $982K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-04-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92014 Ophthalmological E&M | Office | 3,089 | 1,186 | $108.44 | $335K |
| 92134 Computerized Ophthalmic Imaging | Office | 3,041 | 1,157 | $35.68 | $108K |
| 92201 Ophthalmological E&M | Office | 1,824 | 1,083 | $21.20 | $39K |
| 67028 Intravitreal Injection | Office | 1,536 | 214 | $113.54 | $174K |
| 92202 Ophthalmological E&M | Office | 1,313 | 212 | $13.62 | $18K |
| J9035 Injection, bevacizumab, 10 mg | Office | 929 | 131 | $56.65 | $53K |
| J0178 Injection, aflibercept, 1 mg | Office | 250 | 18 | $660.70 | $165K |
| 92004 Ophthalmological E&M | Office | 196 | 196 | $123.95 | $24K |
| 76512 Ultrasound - Nonspecific | Office | 139 | 92 | $44.49 | $6,184 |
| 92250 Angiography | Office | 118 | 107 | $31.79 | $3,751 |
| 92235 Angiography | Office | 57 | 57 | $156.84 | $8,940 |
| 92083 Vision, Hearing, and Speech Services | Office | 17 | 17 | $57.19 | $972 |
By year: 2022 $953K for 10,860 services; 2023 $945K for 11,260 services; 2024 $982K for 12,594 services.
Medicare prescription drug claims, 2024
In 2024, the drug Khurram M Chaudhary prescribed most often to Medicare patients was Eylea (Aflibercept), with 547 prescriptions and refills. In total Khurram M Chaudhary wrote 1,021 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eylea Aflibercept | 547 | 549 | 81 | $1.3M |
| Prednisolone Acetate Generic | 109 | 203 | 57 | $6,881 |
| Ketorolac Tromethamine Generic | 83 | 100 | 28 | $1,582 |
| Vabysmo Faricimab-Svoa | 31 | 31 | Under 11 | $84K |
| Ozurdex Dexamethasone | 21 | 61 | Under 11 | $34K |
| Izervay Avacincaptad Pegol Sodium/Pf | 20 | 20 | Under 11 | $66K |
| Ofloxacin Generic | 20 | 26 | 20 | $308 |
| Latanoprost Generic | 18 | 29 | Under 11 | $130 |
| Lucentis Ranibizumab | 16 | 16 | Under 11 | $43K |
| Bromfenac Sodium Generic | 14 | 14 | Under 11 | $1,772 |
| Dorzolamide Hcl Generic | 13 | 18 | Under 11 | $122 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 13 | 32 | Under 11 | $253 |
| Atropine Sulfate Generic | 13 | 29 | 13 | $806 |
| Eylea Hd Aflibercept | 12 | 12 | Under 11 | $29K |
| Valacyclovir Valacyclovir Hcl | 12 | 16 | Under 11 | $1,977 |
Brand drugs: 793 claims; generic drugs: 228 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Khurram M Chaudhary $1,526 ($1,526 in general payments such as food, travel and fees) from 10 companies. The largest payer was Regeneron Healthcare Solutions, Inc. with $400.
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. REGN | 8 | $400 |
| ANI Pharmaceuticals, Inc. ANIP | 10 | $377 |
| Astellas Pharma US Inc 4503.T | 5 | $238 |
| Abbvie Inc. ABBV | 6 | $180 |
| Genentech USA, Inc. ROG.SW | 2 | $136 |
| Mallinckrodt Hospital Products Inc. | 2 | $63.73 |
| Apellis Pharmaceuticals, Inc. APLS | 2 | $42.25 |
| Oyster Point Pharma, Inc. | 1 | $32.37 |
| Amgen Inc. AMGN | 2 | $30.14 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 1 | $25.67 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.